When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AKTX - Biotech News Recap: Arrowhead Pharmaceuticals Makes Encouraging Progress
Akari Therapeutics Plc
Arrowhead Pharmaceuticals (ARWR) - The company announced that dosing has begun in a new triple combination cohort utilizing JNJ-3989 plus additional undisclosed agents in the ongoing phase 1/2 study in patients with chronic hepatitis B virus. As a result of opening this new cohort, Arrowhead earned a $25 million milestone payment from its larger partner. The overarching goal here is to achieve higher rates of functional cure with a defined treatment duration in these chronic HBV patients. As can be imagined, the market is quite large for HBV with over 250 million people